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The blood brain barrier (BBB) and the blood cerebrospinal fluid barrier (BCSFB) form
the barriers of the brain. These barriers are essential not only for the protection of the
brain, but also in regulating the exchange of cells and molecules in and out of the
brain. The choroid plexus (CP) epithelial cells and the arachnoid membrane form the
BCSFB. The CP is structurally divided into two independent compartments: one formed
by a unique and continuous line of epithelial cells that rest upon a basal lamina; and,
a second consisting of a central core formed by connective and highly vascularized
tissue populated by diverse cell types (fibroblasts, macrophages and dendritic cells).
Here, we review how the CP transcriptome and secretome vary depending on the
nature and duration of the stimuli to which the CP is exposed. Specifically, when
the peripheral stimulation is acute the CP response is rapid, strong and transient,
whereas if the stimulation is sustained in time the CP response persists but it is
weaker. Furthermore, not all of the epithelium responds at the same time to peripheral
stimulation, suggesting the existence of a synchrony system between individual CP
epithelial cells.
Keywords: choroid plexus, epithelial cell, lipocalin 2, inflammation, multiple sclerosis, experimental autoimmune
encephalomyelitis, astrocytes, cerebrospinal fluid
Introduction
The brain is an unusual tissue since it is protected from free exchange with the blood. This is
attained via the presence of blood-brain barriers. Two main barriers exist: the blood-brain barrier
(BBB) and the blood-cerebrospinal fluid (CSF) barrier (BCSFB; Abbott, 2005). The presence
of these barriers contributes, in part, to the central nervous system (CNS) homeostasis. It was
generally accepted that under normal conditions, the BBB and the BCSFB prevent immune cell
entry into the CNS. This view has changed since it is now clearly recognized that activated T cells
are able to cross the brain barriers to perform immune surveillance of the CNS (Engelhardt and
Coisne, 2011).
In this review, we will focus on the BCSFB, located at the choroid plexus (CP) level,
particularly on (i) how the BCSFB provides signals into the brain, in conditions of peripheral
and central inflammation; and on (ii) the specific response of individual CP epithelial cells.
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Choroid Plexus Morphology and Functions
At the CP level, the BCSFB is composed by a monolayer
of epithelial cells that contain tight junctions in the lateral
wall of the CP epithelial cells. This epithelial layer rests in
a basal lamina surrounding and enclosing a central stroma
where dendritic cells, fibroblasts and macrophages can be found.
The blood vasculature that irrigates the CP central stroma
is fenestrated; thus, the cellular movement of molecules and
cells within the CP stroma is not restricted. Ultrastructurally,
the epithelial cells contain a high density of mitochondria,
Golgi apparatus and a smooth endoplasmic reticulum, therefore
demonstrating highly synthetic and secretory capacity. This
is necessary given the CP principal function: the production
of CSF (Speake et al., 2001). The CSF is vital for normal
brain function, ensuring an optimal environment for neuronal
cells. More so, a high number of vesicles with lysosomal
characteristics are present in the CP cytoplasm. Attached
to the apical side of the CP epithelial cells, the epiplexus
cells [also known as Kolmer cells (Pietzsch-Rohrschneider,
1980)], which present macrophage activity, survey the CSF
filled brain ventricles. In addition to these cells, free floating
and supraependymal cells are also observed in the lumen
of the ventricles (Matyszak et al., 1992; McMenamin et al.,
2003; Nataf et al., 2006). These cells, altogether referred as
intraventricular macrophages, are likely to represent the first
line of defense capable to react in brain infections, after bacteria
transverse the CP.
Interestingly, depending on the pathological conditions, the
composition of the stromal compartment is highly changeable,
and may include other peripheral immune cells such as
neutrophils, monocytes, T and B cells (Marques et al., 2012;
Schmitt et al., 2012; Szmydynger-Chodobska et al., 2012).
Necessarily, when addressing the cellular contribution for
the overall CP response, two CP compartments should be
considered: (i) one related to the CP epithelial cells, which
directly influences the composition of the CSF; and (ii) one other
relative to the stromal cells. The latter, can also affect the CP
epithelial cells secretome by secreting molecules that signal the
epithelial cells. Finally, when addressing the CP response, it is
also of relevance the type and duration of stimuli to which the CP
is exposed. This will be next reviewed in the context of peripheral
inflammation.
Acute, Sustained and Attenuated
Responses: Does the CP have an On/Off
System?
How the brain barriers respond to peripheral stimuli, and
how this response is conveyed into the brain, is of great
relevance to understand normal brain homeostasis and diseases
of the CNS. The presence of several receptors and transporters
in the cells that constitute the brain barriers demonstrate
that the barriers are not simple obstacles for molecules and
cells but, also, active metabolic players. The observation that
inflammation seems to be common to most brain disorders
has raised interest on how inflammatory stimuli in the
periphery may trigger events directly or indirectly related to
brain pathology. Thus, studying how the barriers’ respond to
specific inflammatory stimuli/mediators may help understand
their function in disease. The CP response to peripheral
inflammation, studied upon intraperitoneal injection of the
Gram negative bacteria cell wall lipopolyssacharide (LPS)
component, has revealed how differential the response may
be, providing clues on how the communication between the
periphery and the brain is established. Upon a single acute
LPS injection, the CP responds steeply, with alterations in
its transcriptome already detectable upon 1 h, peaking at
3–6 h and returning close to basal levels at 72 h (Marques
et al., 2009a). Of interest, the expression level, in terms of
fold change, observed for some genes is above 50 (Marques
et al., 2009a). Interestingly, if the same stimulus is repeated
every 2 weeks for a period of 3 months, the CP displays an
attenuated response, with few genes presenting fold changes
above 5 (Marques et al., 2009b). These studies indicate that in
the repeated stimulation paradigm, the CP response is sustained
in time, even 15 days after the last LPS injection (Marques
et al., 2009b). Indeed, it seems that the repeated injection
of LPS induces a sustained, albeit ‘‘milder’’, transcription of
specific genes encoding for molecules already found transiently
altered upon a single LPS injection. Interestingly, in the
relapse/remitting experimental autoimmune encephalomyelitis
(EAE) animal model of multiple sclerosis (MS), a condition
of continuous inflammation, the same attenuated response
was been observed (Marques et al., 2012). Specifically, the
expression of several genes is found altered in all phases of the
disease, but with fold changes much smaller when compared
to those observed after a single acute stimulus (Marques et al.,
2009a).
Of interest, the observation regarding the attenuated CP
response to the chronic vs. acute stimulus is not specific
for the inflammatory challenges. In a recent study, the CP
gene expression profile analysis of individuals with major
depressive disorder (a chronic disease) showed that the genes
most altered presented a maximum fold change of 3.5 times
(Turner et al., 2014). In addition, a study with female and male
rats 2 weeks after gonadectomy also suggested that chronic
stimuli are associated with lower fold changes in the CP
gene expression profile. Specifically, although a large number
of differentially expressed genes were detected, the majority
of the genes displayed a 1.5-fold change, when compared to
sham controls, both for males and females (Quintela et al.,
2013). Although it is not know whether the CP response
would be different if the CP was analyzed in a shorter
time point after the surgery, the authors observed that for
females 1168 genes showed a fold increase of 1.5, 422 a
fold increase of 2 and only 11 genes a fold increase of 5.
The same scenario was found for the down-regulated genes.
Altogether, these observations suggest that the CP adapts its
response to the type of stimulus, with a weaker response
under chronic stimulation. Of relevance this is not a specific
response of the CP since it was also shown that the liver
response to acute and chronic stimulus differs (Crispe et al.,
2006).
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FIGURE 1 | Choroid plexus (CP) differential response to acute
vs. sustained inflammation: the case for the lipocalin 2 (LCN2).
The expression of certain CP proteins seems to be influenced by the
duration of the stimulus: acute (A) or sustained (B) peripheral
inflammation. Also even when a stimulus is acute, not all cells are
producing the same protein. Herein is demonstrated the specific
case for LCN2 in response to acute vs. sustained peripheral
inflammation.
Two Compartments, Two Different
Responses
As previously mentioned, two compartments can be found
at the CP level. This distinction is relevant when analyzing
microarray data, since the majority of the studies describe the
CP response as a whole, thus taking into account both epithelial
and stromal cells. It may be necessary to discriminate both
contributions, as they likely influence the brain differently.
Alterations in the CP epithelia transcriptome may directly alter
the CSF composition and the number of transporters and
receptors in the cell membrane; while changes in the stroma
cells transcriptome may result in the secretion of molecules
that may interact with receptors and transporters in the basal
membrane of the epithelial cells, indirectly influencing their
function. This distinction is relevant when analyzing the CP
response to inflammation, infection or even neurodegeneration,
since the composition of the CP stroma is enriched with immune
cells. In accordance, a protein known as lipocalin 2 (LCN2),
a molecule able to bind iron-loaded bacterial siderophores,
is rapidly produced by the CP epithelium when an acute
inflammatory stimulus is induced in the periphery (Marques
et al., 2008). However, when the inflammatory stimulus persists,
it is present solely in neutrophils infiltrating the CP stroma
(Marques et al., 2009b, 2012). These findings suggest that the CP
epithelium shuts down (or attenuates) the response whenever the
system is challenged with prolonged stimulation (Figure 1).
Of note, to exactly pinpoint the origin of particular
changes, the contribution of individual cells, or cell types,
must be determined by using methodologies such as laser
microdissection (Janssen et al., 2013), in situ hybridization
and/or high throughput single cell transcriptomics. For
acute stimulus, the use of in vitro models of CP epithelial
cells (Monnot and Zheng, 2013) might additionally allow a
precise mechanistic dissection of specific signal transduction
pathways.
Are All CP Epithelial Cells Responding
Similarly to a Stimulus?
The characteristic hallmark of the BBB and the BCSFB to
prevent paracellular diffusion is the presence of intercellular
junctions, tight junctions and adherens junctions (Kniesel and
Wolburg, 2000; Vorbrodt and Dobrogowska, 2003), between
endothelial cells of the brain capillaries (Pachter et al., 2003;
Persidsky et al., 2006) and between epithelial cells of the
CP (Szmydynger-Chodobska et al., 2007). Tight and adherens
junctions are known as the principal constituents of the
junctional complex; but, the existence of the transmembrane
connexins proteins, as a third partner in the intercellular
proteins, allows the formation of hemichannels that combine to
form intercellular gap junctions. Although connexins co-exist
within the junctional complex, their role in barrier function of
the BBB and the BCSFB has been mostly ignored. Recently,
and regarding the role of connexins in the brain barriers,
it was shown that the intracellular calcium concentration is
an important factor for the permeability of the BBB and
that this permeability is dependent on the effect of spatially
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propagated intercellular calcium waves through connexins (De
Bock et al., 2012). Also the relevance of connexins in the
intercellular communication of calciumwas shown to be relevant
for endothelial regeneration at the wound site. Additionally
connexins stimulation might trigger proliferative and migratory
behaviors in endothelial cells facing the lesion site (Moccia
et al., 2014). Specifically at the CP epithelium level the role
of connexins in the communication and in the orchestration
of the overall CP response to stimuli, as it happens in the
BBB, has been neglected. This aspect is relevant given the fact
that CP epithelial cells seem to display individual transcription
patterns. In fact, it was observed that while all the epithelial
layer is immunolabeled for the protein transthyretin [encoded
by the gene mostly expressed by the CP epithelial cells (Sousa
et al., 2007)], not all cells label for LCN2 in response to
acute peripheral inflammation (Marques et al., 2008). Therefore,
it seems that not all CP epithelial cells follow the same
response pattern (Figure 1). In future studies, the use of high-
throughput single-cell transcriptomics will determine the extent
and regulation of gene expression variation between identical
cells. It can, nonetheless, be postulated that CP epithelial cells
communicate with each other, through connexins, and that
the individual response of one epithelial cell may influence
the response of the neighboring cell. Of notice, a recent study
showed that preventing cell-to-cell communication substantially
reduced variability between cells in the expression of a set
of early inflammation-related genes (Shalek et al., 2014). This
suggests that paracrine signaling additionally represses part of
the inflammatory program (Shalek et al., 2014). Importantly,
this cell-to-cell communication might control the cellular
heterogeneity and contribute to the overall response of the
system, which has not yet been addressed at the CP level. Another
interesting possibility, for the heterogeneity in the response of
individual CP epithelial cells, may be a differential distribution
in the type and amount of receptors present in each cell. If
this is the case, each CP epithelial cell would be differentially
triggered by the stimuli. Of interest, the expression of connexins
in the CP is also altered in various conditions. Namely, connexin
43 (Cx43) expression is increased during the development of
acute EAE and decreased in the remission phase of the disease
(Jovanova-Nesic et al., 2009). Also, the inner diameter of the
gap junction channels decreases in the CP of acute EAE, as
measured by atomic force microscopy (Jovanova-Nesic et al.,
2009). However, the relevance of these observations is unclear
and deserves to be better explored; to date little is known
regarding the regulation of these connexins in the CP in other
CNS pathologies.
The CP is Activated When the Stimulation
is from the Brain to the Periphery: Recent
Relevant Findings
Inflammation in the CNS (termed neuroinflammation) is
common to all neurodegenerative conditions and whenever
an injury is imposed in the CNS. In the resolution of
neuroinflammation both resident and infiltrating immune cells
play a role. Concerning the recruitment of peripheral cells,
and unlike the BBB, the CP constitutively expresses adhesion
molecules and chemokines, which support the preferential and
initial transepithelial leukocyte trafficking across the CP (Steffen
et al., 1996; Kunis et al., 2013). Of interest, it was shown
that in situations of brain inflammation, as is the case of
traumatic brain injury, neutrophils reach the CSF through
the CP and accumulate in the CSF space near the injury
site, from where they may migrate to the brain parenchyma
(Szmydynger-Chodobska et al., 2009). Similarly, it has been
suggested that the initial migration of Th17 cells into the
brain parenchyma in the EAE animal model (Reboldi et al.,
2009) occurs at the CP, and that monocytes migrate through
the CP on their way to the lesion site in a spinal cord
injury model (Shechter et al., 2013). In addition, the entry
of cells into the brain through the CP is likely due to the
basal expression of adhesion molecules in the epithelial cells,
and also to the enrichment of the CP stroma with CD4+
T cells specific for CNS antigens, even in basal conditions
(Baruch and Schwartz, 2013; Kunis et al., 2013). A recent
work showed that in normal aging the expression of interferon
type I (IFN-I) dependent genes [intercellular adhesion molecule
1(IFN-β) and interferon regulatory factor 7 (IRF7)] is strongly
increased in the CP; whereas, interferon type II (IFN-II)
dependent genes [intercellular adhesion molecule 1 (ICAM1)
and interferon gamma-induced protein 10 (Cxcl10)] expression
is found decreased (Baruch et al., 2014). This may indicate a
decrease in the immune cell recruitment to the brain at least
through the CP (Baruch et al., 2014). In addition, this age-
associated IFN-II expression program is modulated by both
circulation and brain-derived factors, whereas that of IFN-I
seems more likely to be influenced by CSF-born factors in the
aged brain (Baruch et al., 2014).
Future studies should, therefore, not only study the CP
expression profile in diseases such as Alzheimer’s disease (AD),
but also the overall CP response to inflammatory stimulus
elicited both in the circumventricular space and within the brain
parenchyma. In such an approach it would also be interesting
to evaluate the interaction between epithelial and dendritic
cells in regulating antigen sensitization to the periphery. It
has been shown in the intestine and in the airways epithelia
that intraepithelial dendritic cells extend processes into the
intestinal and the airway lumen, respectively, to collect antigenic
material from the mucosa surface (Kato and Schleimer, 2007;
Schleimer et al., 2007; Shaykhiev and Bals, 2007). Whether
such interaction also occurs between the dendritic cells within
the CP epithelium and the ventricular space of the brain is
of great relevance in understanding CNS diseases. One other
relevant future challenge is the potential role of the CP as a
modulator of CNS disorders namely neurodegenerative diseases.
Of relevance the results showing that molecules produced by
the CP impact on brain function (such as cognition) and
brain repair represent an important starting point to tackle
neurodegeneration. Also the role of the CP as the initial entry
gate for immune cells access to the brain might be used and
modulated aiming to decrease neuroinflammation associated
with diseases such as MS.
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